Y. Vivienne Marsh

530 total citations
17 papers, 439 citations indexed

About

Y. Vivienne Marsh is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Y. Vivienne Marsh has authored 17 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Y. Vivienne Marsh's work include Herpesvirus Infections and Treatments (5 papers), Virus-based gene therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Y. Vivienne Marsh is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), Virus-based gene therapy research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Y. Vivienne Marsh collaborates with scholars based in United States, Poland and France. Y. Vivienne Marsh's co-authors include Deborah A. Eppstein, Alain B. Schreiber, Brian Schryver, John J. Nestor, George J. Todaro, E B Fraser-Smith, Thomas R. Matthews, Abla A. Creasey, Zafar Iqbal Khan and T. C. Merigan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Y. Vivienne Marsh

17 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Vivienne Marsh United States 13 182 136 122 93 76 17 439
R H Neubauer United States 8 222 1.2× 64 0.5× 138 1.1× 81 0.9× 88 1.2× 12 452
Wilhelm Bannwarth Switzerland 8 323 1.8× 73 0.5× 220 1.8× 98 1.1× 85 1.1× 11 705
D Bizub United States 9 258 1.4× 99 0.7× 44 0.4× 77 0.8× 107 1.4× 10 452
N. Kluge Germany 10 287 1.6× 60 0.4× 126 1.0× 174 1.9× 66 0.9× 24 616
A. T. Jamieson Slovakia 11 258 1.4× 496 3.6× 159 1.3× 212 2.3× 123 1.6× 17 712
H. U. Schwenk Germany 6 311 1.7× 72 0.5× 314 2.6× 64 0.7× 142 1.9× 13 705
Jerome Schwartz United States 14 284 1.6× 281 2.1× 90 0.7× 111 1.2× 118 1.6× 29 665
Jeffrey Ross United States 9 434 2.4× 143 1.1× 96 0.8× 208 2.2× 78 1.0× 11 733
R A Jupp United Kingdom 9 249 1.4× 58 0.4× 41 0.3× 87 0.9× 69 0.9× 12 412
Arthur H. Hale United States 14 270 1.5× 120 0.9× 231 1.9× 116 1.2× 46 0.6× 51 608

Countries citing papers authored by Y. Vivienne Marsh

Since Specialization
Citations

This map shows the geographic impact of Y. Vivienne Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Vivienne Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Vivienne Marsh more than expected).

Fields of papers citing papers by Y. Vivienne Marsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Vivienne Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Vivienne Marsh. The network helps show where Y. Vivienne Marsh may publish in the future.

Co-authorship network of co-authors of Y. Vivienne Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Vivienne Marsh. A scholar is included among the top collaborators of Y. Vivienne Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Vivienne Marsh. Y. Vivienne Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lancz, Gerald, et al.. (1990). Inhibition of Vesicular Stomatitis Virus Replication in Dexamethasone-Treated L929 Cells. Experimental Biology and Medicine. 193(3). 190–196. 5 indexed citations
2.
Eppstein, Deborah A., Y. Vivienne Marsh, Brian Schryver, & Paul J. Bertics. (1989). Inhibition of epidermal growth factor/transforming growth factor‐α–stimulated cell growth by a synthetic peptide. Journal of Cellular Physiology. 141(2). 420–430. 36 indexed citations
3.
Eppstein, Deborah A., et al.. (1988). Enhanced Antitumor Efficacy of Adriamycin in Combination with Interferon-γ: Effects on Macrophages. Journal of Interferon Research. 8(3). 263–273. 9 indexed citations
4.
Marsh, Y. Vivienne & Deborah A. Eppstein. (1987). Vaccinia virus and the EGF receptor: A portal for infectivity?. Journal of Cellular Biochemistry. 34(4). 239–245. 12 indexed citations
5.
Eppstein, Deborah A., Brian Schryver, & Y. Vivienne Marsh. (1986). Stereoconfiguration markedly affects the biochemical and biological properties of phosphorothioate analogs of 2-5A core, (A2'p5')2A.. Journal of Biological Chemistry. 261(13). 5999–6003. 19 indexed citations
6.
Eppstein, Deborah A., et al.. (1985). Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor.. Proceedings of the National Academy of Sciences. 82(11). 3688–3692. 36 indexed citations
7.
Eppstein, Deborah A., et al.. (1985). Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature. 318(6047). 663–665. 110 indexed citations
8.
Fraser-Smith, E B, Deborah A. Eppstein, Y. Vivienne Marsh, & Thomas R. Matthews. (1985). Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with gamma interferon against herpes simplex virus type 2 in mice. Antiviral Research. 5(3). 137–144. 14 indexed citations
9.
Fraser-Smith, E B, Deborah A. Eppstein, Y. Vivienne Marsh, & Thomas R. Matthews. (1984). Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice. Antimicrobial Agents and Chemotherapy. 26(6). 937–938. 30 indexed citations
10.
Eppstein, Deborah A. & Y. Vivienne Marsh. (1984). Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy) methyl]guanine in combination with recombinant interferons. Biochemical and Biophysical Research Communications. 120(1). 66–73. 22 indexed citations
11.
Fraser-Smith, E B, Deborah A. Eppstein, Y. Vivienne Marsh, & Thomas R. Matthews. (1984). Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice. Antimicrobial Agents and Chemotherapy. 25(5). 563–565. 17 indexed citations
12.
Eppstein, Deborah A., et al.. (1983). Dephosphorylated Core of 2′-5′ Oligoadenylate Exerts Its Antimitogenic Effect through Mechanisms Different from the 2′-5′A-Dependent Endonuclease. Journal of Interferon Research. 3(3). 305–311. 20 indexed citations
13.
Eppstein, Deborah A. & Y. Vivienne Marsh. (1983). Partial Dissociation of Antiviral and Antimitogenic Activities of Murine Interferon after Its Incorporation into Liposomes. Journal of Interferon Research. 3(2). 161–168. 5 indexed citations
14.
Creasey, Abla A., et al.. (1983). Growth Regulation of Melanoma Cells by Interferon and (2′-5′)Oligoadenylate Synthetase. Molecular and Cellular Biology. 3(5). 780–786. 13 indexed citations
15.
Eppstein, Deborah A., Y. Vivienne Marsh, & Brian Schryver. (1983). Mechanism of antiviral activity of (XyloA2′p)2XyloA. Virology. 131(2). 341–354. 15 indexed citations
16.
Creasey, Abla A., Deborah A. Eppstein, Y. Vivienne Marsh, Zafar Iqbal Khan, & T. C. Merigan. (1983). Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase.. Molecular and Cellular Biology. 3(5). 780–786. 55 indexed citations
17.
Eppstein, Deborah A., et al.. (1983). Xyloadenosine analogue of (A2′p)2A inhibits replication of herpes simplex viruses 1 and 2. Nature. 302(5910). 723–724. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R H Neubauer Breakdown of academic impact, for papers by Wilhelm Bannwarth Breakdown of academic impact, for papers by D Bizub Breakdown of academic impact, for papers by N. Kluge Breakdown of academic impact, for papers by A. T. Jamieson Breakdown of academic impact, for papers by H. U. Schwenk Breakdown of academic impact, for papers by Jerome Schwartz Breakdown of academic impact, for papers by Jeffrey Ross Breakdown of academic impact, for papers by R A Jupp Breakdown of academic impact, for papers by Arthur H. Hale
Rankless by CCL
2026